Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 2Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Colorectal Neoplasms 43Squamous Cell Carcinoma of Head and Neck 12Rectal Neoplasms 12Colonic Neoplasms 12Neoplasm Metastasis 9Head and Neck Neoplasms 8Esophageal Squamous Cell Carcinoma 4Esophageal Neoplasms 4Colorectal Cancer Metastatic 3Carcinoma, Non-Small-Cell Lung 3Carcinoma 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Oropharyngeal Neoplasms 2Neoplasms 2Nasopharyngeal Carcinoma 2Carcinoma, Squamous Cell 2mCRC 1Stomach Neoplasms 1Skin Neoplasms 1Recurrence 1Neoplasms, Unknown Primary 1Nasopharyngeal Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Liver Metastasis Colon Cancer 1Incurable Colorectal Cancer 1Glioblastoma 1Gastrointestinal Neoplasms 1Gallbladder Neoplasms 1

Interventions

Temozolomide 44Radiotherapy 16Bevacizumab 9Surgical Procedures, Operative 5Carmustine 5pembrolizumab 4Lomustine 4Drug Therapy 4Sunitinib 3Standard of Care 3Radiation 3Procarbazine 3Irinotecan 3Granulocyte-Macrophage Colony-Stimulating Factor 3Chlorotoxin 3Carboplatin 3Blood Specimen Collection 3tislelizumab 2fludarabine 2camrelizumab 2Radiosurgery 2Neoadjuvant Therapy 2Magnetic Resonance Spectroscopy 2Hyperbaric Oxygenation 2Ethanol 2Cyclophosphamide 2Chemotherapy, Adjuvant 2CT-322 2Bortezomib 2Aminolevulinic Acid 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Glioblastoma × Cetuximab × Clear all
NCT00311857 2006-09-08

Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)

Heidelberg University

Phase 1/2 Unknown
46 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡